‘Life-Altering’: FDA Approves Pancreatic Cancer Drug

FDA approves first-of-its-kind pill for advanced pancreatic cancer six months early

By Rajwa Quasim The Food and Drug Administration (FDA) gave expedited approval this week to a first-of-its-kind pill for advanced pancreatic cancer, one of the deadliest forms of cancer. FDA regulators said Wednesday that the drug was approved more than six months ahead of schedule. The approved drug, daraxonrasib, will be sold under the brand name Rasonque by Revolution Medicines. The drug targets a mutated protein responsible for driving tumor…

St. Charles Offers Groundbreaking Pancreatic Cancer Medication

Patients at St. Charles Cancer Institute are receiving a ‘game changing’ medication found to double life expectancy for patients with stage 4 metastatic pancreatic cancer. Seven patients with St. Charles began receiving the medication daraxonrasib earlier this month, through expanded access that allows access to prescription drugs prior to approval from the Food and Drug Administration (FDA). The medication was approved by the FDA Aug. 26. While…

U.S. FDA approves landmark pancreatic cancer drug

Revolution’s daraxonrasib pill blocks a mutated protein that fuels tumour growth in more than 90% of pancreatic cancer cases

FDA Approves 'Landmark' Cancer Drug That Extended Patients' Lives in Trial

The Food and Drug Administration announced Wednesday the approval of a new pancreatic cancer treatment drug that nearly doubles patients’ survival times. Former GOP Sen. Ben Sasse of Nebraska has […] The post FDA Approves 'Landmark' Cancer Drug That Extended Patients' Lives in Trial appeared first on The Western Journal.

‘Life-altering’: FDA approves pancreatic cancer drug

“We’ve never seen a benefit like this,” said Anna Berkenblit, the chief scientific and medical officer at the Pancreatic Cancer Action Network.

FDA approves Ben Sasse's 'miracle' pancreatic cancer drug

The drug is now available in the U.S. at a price of $39,800 for a 30-day supply.